🇺🇸 FDA
Patent

US 8063211

Rosuvastatin and salts thereof free of rosuvastatin alkylether and a process for the preparation thereof

granted A61PA61P3/06

Quick answer

US patent 8063211 (Rosuvastatin and salts thereof free of rosuvastatin alkylether and a process for the preparation thereof) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Nov 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TEVA PHARMACEUTICAL INDUSTRIES, LTD.
Grant date
Tue Nov 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61P, A61P3/06